Regulation of p21(WAF1) Expression During Normal Myeloid Differentiation
Open Access
- 15 June 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 91 (12) , 4531-4542
- https://doi.org/10.1182/blood.v91.12.4531
Abstract
The G1-phase cell-cycle inhibitor p21 has been proposed to mediate growth arrest during differentiation. Upregulation of p21 has been shown in multiple cell lines induced to differentiate; however, the mechanism of p21 induction during normal differentiation is largely unknown. In this report, we use normal hematopoietic precursor cells obtained from umbilical cord to model p21 regulation during differentiation. Myeloid maturation of CD34+ precursor cells is associated with a marked increase in p21 expression at the RNA and protein level. The upregulation of p21 transcripts during differentiation is associated with decreased binding to a highly conserved 44-bp fragment within the p21 promoter. This 44-bp regulatory element binds a novel modulator of p21 expression. It is of considerable interest that, although the binding activity is expressed in p53-negative as well as in p53-positive cells, the DNA sequence recognized by this protein overlaps a PuPuPuC(A/T)(T/A)GPyPyPy consensus sequence for p53.Keywords
This publication has 57 references indexed in Scilit:
- In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiationOncogene, 1997
- Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21 WAF1/CIP1 Mediated by STAT1Science, 1996
- A Novel CCAAT-binding Protein Necessary for Adhesion-dependent Cyclin A Transcription at the G1/S Boundary Is Sequestered by a Retinoblastoma-like Protein in G0Published by Elsevier ,1996
- The Role of the Transcription Factor Sp1 in Regulating the Expression of the WAF1/CIP1 Gene in U937 Leukemic CellsPublished by Elsevier ,1996
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.Genes & Development, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Induction of differentiation and c‐jun expression in human leukemic cells by okadaic acid, an inhibitor of protein phosphatasesJournal of Cellular Physiology, 1992
- Definition of a consensus binding site for p53Nature Genetics, 1992
- Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiationCell, 1989